Stocks · Healthcare · Medical - Instruments & Supplies
STAAR Surgical Company STAA
$22.47 +0.40% Close, Oct 2, 2026 · NASDAQ · Market cap $1.12B
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 10.3% from -48.8% a year earlier.
- Revenue over the last four quarters was $339.6M, up 51.3% from a year earlier, accelerating from 4.0% a quarter earlier.
- The shares trade at 280.9× trailing earnings, higher than 87% of the company's own readings over the past five years.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 17%
- Revenue growth, 3-year CAGRBottom 15%
- Revenue growth accelerationTop 6%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 29%
- Gross marginTop 35%
- Operating marginTop 26%
- Cash conversion (OCF / net income)Bottom 2%
- Accruals (lower is better)Bottom 14%
- Net debt / EBITDA (lower is better)Top 9%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 29%
- Free-cash-flow yieldTop 38%
- EBITDA / enterprise valueTop 30%
- Sales / enterprise valueTop 39%
- P/E vs own 5-year history (lower is better)Bottom 14%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 26%
- 6-month returnTop 47%
- 1-year return vs S&P 500Bottom 31%
- Distance from 52-week highBottom 43%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 4%
- Upside to consensus price targetBottom 39%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 49%
- Maximum drawdown, 3 yearsBottom 49%
- Beta vs S&P 500 (lower is better)Top 49%
- Net debt / EBITDA (lower is better)Top 9%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 4.0% | 51.3% | ↑ |
| Gross margin | 71.7% | 76.2% | ↑ |
| Operating margin | -48.8% | 10.3% | ↑ |
| FCF margin | -19.5% | -2.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 51.3% | 4.0% | ↑ | Top 17% |
| Gross margin | 76.2% | 71.7% | ↑ | Top 35% |
| Operating margin | 10.3% | -48.8% | ↑ | Top 26% |
| Net margin | 1.1% | -42.4% | ↑ | — |
| Free-cash-flow margin | -2.0% | -19.5% | ↑ | — |
| Return on invested capital | 1.9% | — | Top 29% | |
| Revenue growth, 3-year CAGR | -5.6% | — | Bottom 15% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -0.85×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 1.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 8.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +123.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -3.51×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.47%
- Shareholder yield
- 0.47%
- Share count change, 1 year
- +4.0%
- Share count change, 3-year CAGR
- +1.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 3, 2026 (filed Aug 12, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +0.4%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $30.89
- Target vs current price
- +37.5%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 31%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 12, 2026 | -27.7% | +1.9% | -1.2% | -5.3% | — |
| May 13, 2026 | +600.8% | +4.3% | +15.7% | +4.1% | -14.1% |
| Mar 3, 2026 | -211.1% | -0.7% | -3.8% | -3.7% | +64.8% |
| Nov 5, 2025 | +155.6% | -0.1% | +8.4% | +4.3% | -28.6% |
| Aug 6, 2025 | +39.4% | -0.4% | +1.4% | +1.1% | -1.6% |
| May 7, 2025 | +11.9% | +4.3% | +1.9% | -10.6% | -4.7% |
| Feb 11, 2025 | -2600.0% | -3.2% | -26.4% | -18.9% | -14.0% |
| Oct 30, 2024 | +94.7% | -2.6% | -0.9% | -7.4% | -17.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 12, 2026 | $0.16 | $0.22 | -27.7% | $93.5M |
| May 13, 2026 | $0.38 | $0.05 | +600.8% | $93.5M |
| Mar 3, 2026 | -$0.20 | $0.18 | -211.1% | $57.8M |
| Nov 5, 2025 | $0.46 | $0.18 | +155.6% | $94.7M |
| Aug 6, 2025 | -$0.34 | -$0.56 | +39.4% | $44.3M |
| May 7, 2025 | -$0.52 | -$0.59 | +11.9% | $42.6M |
| Feb 11, 2025 | -$0.50 | $0.02 | -2600.0% | $49.0M |
| Oct 30, 2024 | $0.37 | $0.19 | +94.7% | $88.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 280.9× | 108.7× | 87th | Top 29% |
| P/E (forward) | 77.4× | — | — | — |
| EV / EBITDA | 31.4× | — | — | Top 30% |
| EV / Sales | 2.96× | — | — | Top 39% |
| Free-cash-flow yield | -0.60% | — | — | Top 38% |
| Earnings yield | 0.36% | — | — | Top 29% |
P/E over the past five years
Range 66.8× – 317.6× since Jul 2, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.7%
- 200-day average slope (20 days)
- -1.6%
- Distance from 50-day average
- -2.4%
- Distance from 200-day average
- -5.1%
- RSI (14)
- 51.7
- Relative volume
- 0.53×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 54.9%
- Volatility vs own 5-year history
- 37th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.10
- Correlation with S&P 500
- 0.25
- Current drawdown from 1-year high
- -32.6%
- Maximum drawdown, 3 years
- -71.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 7, 2021 | Apr 8, 2025 | -90.7% | 900 days | Not yet recovered |
| Feb 16, 2021 | Mar 8, 2021 | -37.5% | 14 days | 31 days (Apr 21, 2021) |
| Apr 29, 2021 | May 13, 2021 | -23.6% | 10 days | 10 days (May 27, 2021) |
| Jun 24, 2021 | Jul 27, 2021 | -20.8% | 22 days | 7 days (Aug 5, 2021) |
| Aug 5, 2021 | Aug 20, 2021 | -16.3% | 11 days | 8 days (Sep 1, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.12B
- P/E (TTM)
- 280.9
- EPS, diluted (TTM)
- $0.08
- Revenue (TTM)
- $339.6M
- 52-week range
- $15.59 – $35.87
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $230.5M | $284.4M | $322.4M | $313.9M | $239.4M |
| Gross profit | $178.6M | $223.4M | $252.7M | $239.6M | $182.4M |
| Operating income | $33.3M | $43.8M | $28.1M | -$12.6M | -$45.9M |
| Net income | $27.5M | $39.7M | $21.3M | -$20.2M | -$80.4M |
| EPS (diluted) | $0.50 | $0.80 | $0.43 | -$0.41 | -$1.62 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $88.6M | $49.0M | $42.6M | $44.3M | $94.7M | $57.8M | $93.5M | $93.5M |
| Net income | $10.0M | -$34.2M | -$54.2M | -$16.8M | $8.9M | -$18.3M | $5.2M | $8.1M |
| EPS (diluted) | $0.20 | -$0.69 | -$1.10 | -$0.34 | $0.18 | -$0.36 | $0.10 | $0.16 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $44.0M | $35.7M | $14.6M | $15.7M | -$34.2M |
| Capital expenditure | -$13.6M | -$18.1M | -$18.2M | -$23.4M | -$5.8M |
| Free cash flow | $30.3M | $17.6M | -$3.6M | -$7.7M | -$40.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $1,000 | $1,000 | -$2.1M | -$1.5M | -$3.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $181.5M
- Total assets
- $475.2M
- Total liabilities
- $109.8M
- Total debt
- $35.9M
- Net debt
- -$112.6M
- Shareholders’ equity
- $365.4M
As of Jul 3, 2026 (filed Aug 12, 2026).
Short interest
- Shares sold short
- 4,631,284
- Days to cover
- 4.87
- Change vs previous report
- +8.6%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- May 18, 1992
- 1-for-2
- Nov 1, 1990
- 1-for-2
- Nov 9, 1984
- 2-for-1
- Jul 3, 1984
- 2-for-1